Erratum: Role of nociceptors/neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease (Digestive Diseases and Sciences DOI: 10.1007/s10620-012-2337-7);Role of nociceptors/neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease

Digestive Diseases and Sciences

Volumn 58, Issue 8, 2013, Pages 2237-2243

  Yoshida, Norimasa ^a,b   Kuroda, Masaaki ^b   Suzuki, Takahiro ^a   Kamada, Kazuhiro ^b   Uchiyama, Kazuhiko ^b   Handa, Osamu ^b   Takagi, Tomohisa ^b   Yoshikawa, Toshikazu ^b   Kuramoto, Hirofumi ^c  

^a KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Neurokinin 1 receptor (NK1R); Nonerosive reflux disease (NERD); Protease activated receptor 2 (PAR2); Substance P; Transient receptor potential vanilloid 1 (TRPV1); Visceral hypersensitivity

Indexed keywords

ACID SENSING ION CHANNEL; ACID SENSING ION CHANNEL 3; CALCITONIN GENE RELATED PEPTIDE; MESSENGER RNA; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE; PROTEINASE ACTIVATED RECEPTOR 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; SUBSTANCE P; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; FEMALE; HEARTBURN; HUMAN; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MALE; NON EROSIVE REFLUX DISEASE; PAIN RECEPTOR; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VISCERAL HYPERSENSITIVITY;

EID: 84881474913     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2505-9     Document Type: Erratum

References (30)

1. Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol. 2004;2:656-664.
2. Tytgat GN. Review article: treatment of mild and severe cases of GERD. Aliment Pharmacol Ther. 2002;16:73-78.
3. Yoshida N, Yoshikawa T. Defense mechanism of the esophageal mucosa and esophageal inflammation. J Gastroenterol. 2003;38:31-34.
4. Yoshida N, Uchiyama K, Kuroda M, et al. IL-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease. Scand J Gastroenterol. 2004;39:816-822.
5. Yoshida N. Inflammation and oxidative stress in gastroesophageal reflux disease. J Clin Biochem Nutr. 2007;40:13-23.
6. Barlow WL, Orlando RC. The pathogenesis of heartburn in nonerosive reflux disease: a unifying hypothesis. Gatroenterology. 2005;128:771-778.
7. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut. 1995;37:7-12.
8. Miwa H, Minoo T, Hojo M, et al. Oesophageal hypersensitivity in Japanese patients with non-erosive gastro-oesophageal reflux diseases. Aliment Pharmacol Ther. 2004;20:112-117.
9. Matthews PJ, Aziz Q, Facer P, Davis JB, Thompson DG, Anand P. Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus. Eur J Gastroenterol Hepatol. 2004;16:897-902.
10. Bhat YM, Bielefeldt K. Capsaicin receptor (TRPV1) and non-erosive reflux disease. Eur J Gastroenterol Hepatol. 2006;18:263-270.
11. Wick EC, Hoge SG, Grahn SW, et al. Transient receptor potential vanilloid 1, calcitonin gene-related peptide, and substance P mediate nociception in acute pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2006;290:G959-G969.
12. Engel MA, Khalil M, Mueller-Tribbensee SM, et al. The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons. J Gastroenterol. 2012;47:256-265.
13. Muñoz M, Coveñas R. NK-1 receptor antagonists: a new paradigm in pharmacological therapy. Curr Med Chem. 2011;18:1820-1831.
14. Tillisch K, Labus J, Nam B, et al. Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: a pilot study. Aliment Pharmacol Ther. 2012;35:360-367.
15. Marquez de Prado B, Hammond DL, Russo AF. Genetic enhancement of calcitonin gene-related peptide-induced central sensitization to mechanical stimuli in mice. J Pain. 2009;10:992-1000.
16. Cottrell GS, Alemi F, Kirkland JG, Grady EF, Corvera CU, Bhargava A. Localization of calcitonin receptor-like receptor (CLR) and receptor activity-modifying protein 1 (RAMP1) in human gastrointestinal tract. Peptides. 2012;35:202-211.
17. Yoshida N, Yoshikawa T. Basic and translational research on proteinase-activated receptors: implication of proteinase/proteinase-activated receptor in gastrointestinal inflammation. J Pharmacol Sci. 2008;108:415-421.
18. Vergnolle N, Bunnett NW, Sharkey KA, et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med. 2001;7:821-826.
19. Bunnett NW. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain. Semin Throm Hemost. 2006;32:39-48.
20. Huang SC. Protease-activated receptor-1(PAR1) and PAR2 but not PAR 4 mediate relaxations in lower esophageal sphincter. Regul Pept. 2006;142:37-43.
21. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol. 1998;33:1023-1029.
22. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7:75-83.
23. Pan XQ, Gonzalez JA, Chang S, Chacko S, Wein AJ, Malykhina AP. Experimental colitis triggers the release of substance P and calcitonin gene-related peptide in the urinary bladder via TRPV1 signaling pathways. Exp Neurol. 2010;225:262-273.
24. Humes DJ, Simpson J, Smith J, et al. Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and low grade inflammation. Neurogastroenterol Motil. 2012;24:318-1630.
25. Guarino MP, Cheng L, Ma J, et al. Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease. Neurogastroenterol Motil. 2010;22:746-751.
26. Tohda C, Sasaki M, Konemura T, et al. Axonal transport of VR1 capsaicin receptor mRNA in primary afferents and its participation in inflammation-induced increase in capsaicin sensitivity. J Neurochem. 2001;76:1628-1635.
27. Banerjee B, Medda BK, Lazarova Z, Bansal N, Shaker R, Sengupta JN. Effect of reflux-induced inflammation on transient receptor potential vanilloid one (TRPV1) expression in primary sensory neurons innervating the oesophagus of rats. Neurogastroenterol Motil. 2007;19:681-691.
28. Suzuki T, Yoshida N, Mizushima K, et al. TRPV1 expression associated with nerve growth factor mediates the esophageal visceral hypersensitivity. Gastroenterology. 2008;134:A-589-A-590.
29. Yoshida N, Katada K, Handa O, et al. Interleukin-8 production via protease-activated receptor 2 in human esophageal epithelial cells. Int J Mol Med. 2007;19:335-340.
30. Emerenziani S, Sifrim D, Habib FI, et al. Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus. Gut. 2008;57:443-447.